Cardior Pharmaceuticals: Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins

Related Keywords

United States ,American ,Russell Greig ,Claudia Ulbrich ,Kostenloser Wertpapierhandel ,Eva Mulder ,Claudia Ulbrich Eva ,University Of Minnesota Medical School ,University Of Minnesota ,Cardior Pharmaceuticals Gmb ,Trophic Communications ,Cardior Pharmaceuticals ,Orly Vardeny ,Minnesota Medical School ,Associate Editor ,Heart Failure ,American College ,Heart Failure Society ,America Guidelines ,Claudia Ulbrich Eva Stra ,Pharmaceuticals Gmbh ,Cardior ,Pharmaceuticals ,Elcomes ,Orly ,Ardeny ,Permanent ,Guest ,Board ,